Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 57Neoplasm Metastasis 21Carcinoma, Non-Small-Cell Lung 9Stomach Neoplasms 8Brain Neoplasms 8Colorectal Neoplasms 7Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Recurrence 3Neoplasms 3Esophageal Neoplasms 3Adenocarcinoma 3Prostatic Neoplasms 2Meningeal Carcinomatosis 2HER2-positive Gastric Cancer 2Colonic Neoplasms 2Breast Cancer With Brain Metastasis 2Advanced Solid Tumor 2Advanced Breast Cancer 2Adenocarcinoma Of Esophagus 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unresectable Locally Recurrent Breast Cancer 1

Interventions

Letrozole 5Fulvestrant 5trastuzumab deruxtecan 2toripalimab 2sacituzumab govitecan 2palbociclib 2elacestrant 2abemaciclib 2Injections 2Anastrozole 2AZD9833 2ribociclib 1pyrotinib 1exemestane 1eribulin 1disitamab vedotin 1dalpiciclib 1Vinorelbine 1Selective Estrogen Receptor Modulators 1Ritonavir 1RAD1901 1Paclitaxel 1Lead 1Itraconazole 1Goserelin 1Gonadotropin-Releasing Hormone 1Everolimus 1Docetaxel 1Bevacizumab 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Breast Cancer × trastuzumab deruxtecan × 1 year × Clear all
NCT06486883 2026-06-02

PONTIAC

MedSIR

Phase 2 Recruiting
200 enrolled
Breast

Advanced Breast Cancer

NCT07180264 2025-11-18

Trastuzumab Deruxtecan in Advanced Breast Cancer

RenJi Hospital

Recruiting
118 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡